 [23] 
  In support of their motion, the Defendants point to Dr. Sherman's testimony on cross-examination where he stated that it is Apotex's belief that SPIL is the parent company of Roche and as such, the parent company was giving direction. Further, the Defendants point to Dr. Sherman's comments that Apotex will know which companies have to be named in its action for damages after discovery of the Defendants. 
